BioSpace News Archive

Endo International plc announced that Endo Finance LLC, a wholly-owned subsidiary of the Company, has commenced a cash tender offer for any and all of its outstanding 5.75% Senior Notes due 2022, on the terms and subject to the conditions set forth in the Offer to Purchase, dated as of the date hereof and the related Notice of Guaranteed Delivery attached to the Offer to Purchase.

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that management will participate in a fireside chat at The JMP Securities CNS Forum on Wednesday, August 19, 2020 at 2:00 PM ET. About Axial Biotherapeutics Axial Biotherapeutics is a clinical stage biopharmaceutical comp

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the enrollment of the first patient in the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05). The PATHFINDER I Registry is a pilot study to evaluate the safety and efficacy of the Auryon Atherectomy System in the real

Walgreens taking proactive measures in preparation for flu season to meet customer demand and ensure the health and safety of communities during COVID-19 pandemic

Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the “Company”) focused on commercializing novel products that address significant patient needs, today announced the delivery of Healight™ investigational devices

XBiotech Inc. (NASDAQ: XBIT) announced today that it has identified True Human antibodies that could potentially be used as a therapy against SARS-CoV2, the virus that causes COVID-19. The Company discovered these antibodies through a collaboration with BioBridge Global (parent organization of the South Texas Blood & Tissue Center and QualTex Laboratories, one of the largest independent testing laboratories in the United States). For the c

InStep Health, a healthcare marketing company that supports pharma, OTC, and CPG marketers in reaching patients, healthcare providers, and consumers, announces forward-facing additions to its executive team

$20 Million Memorandum of Understanding completed with an investor for a strategic upmarket transaction $10 Million financing proposal in the same MOU for the acquisition of infectious disease and cancer diagnostics company awaiting EUA approval from FDA for COVID-19 rapid diagnostic assay system ALTuCELL acquisition update NuGenHealth SaaS Remote Patient Monitoring and Chronic Care Management 50% Partnership Completed a Memorandum of Understanding Regarding Development partnership for Ii-Ke

Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, points to its role in taking a patient-first approach for providing personalized medicine as a more precise basis to predict the prognosis of genetic diseases.

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced that its subsidiary Primus Corporation has received a warning letter from the U.S. Food and Drug Administration (FDA) following an inspection of its Kansas City, Missouri manufacturing facility that took place in January 2020. The issues identified in this letter primarily relate to th